Rosalind Advisors, Inc. - 30 Sep 2025 SCHEDULE 13G Report for FENNEC PHARMACEUTICALS INC. Common Shares (FENC)

Filing Manager
Rosalind Advisors, Inc.
Reporting Manager
Rosalind Advisors, Inc.
Security
FENNEC PHARMACEUTICALS INC. Common Shares
Symbol
FENC
Shares outstanding
27,691,200 shares
Disclosed Ownership
2,076,840 shares
Ownership
7.5%
Form type
SCHEDULE 13G
Filing time
13 Nov 2025, 16:08:51 UTC
Date of event
30 Sep 2025
Next filing
11 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Rosalind Advisors, Inc. disclosed 7.5% ownership in FENNEC PHARMACEUTICALS INC. Common Shares (FENC) on 30 Sep 2025."

Quick Takeaways

  • Rosalind Advisors, Inc. filed SCHEDULE 13G for FENNEC PHARMACEUTICALS INC. Common Shares (FENC).
  • Disclosed ownership: 7.5%.
  • Date of event: 30 Sep 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Nov 2025, 16:08.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rosalind Advisors, Inc. 7.5% 2,076,840 0 2,076,840 Steven Salamon President
SALAMON STEVEN A J 7.5% 2,076,840 0 2,076,840 Steven Salamon Steven Salamon
Aharon Gil 7.5% 2,076,840 0 2,076,840 Gil Aharon Gil Aharon
Rosalind Master Fund L.P. 7.5% 2,076,840 0 2,076,840 Mike McDonald Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)

Sponsored